The FDA’s Center for Drug Evaluation and Research (CDER) posted 40 Untitled Letters to pharmaceutical companies over direct-to-consumer (DTC) ads on Sept. 16. All the letters were signed by CDER director George Tidmarsh. All but four of the letters to 22 companies dealt with television ads. The four non-TV ads were for a DTC print ad, DTC video interviews, “background and vid... Read More